Health care industry stakeholders should “begin talking” about addressing rising prescription drug costs before the federal government is forced to step in, according to America’s Health Insurance Plans President and CEO Karen Ignagni, The Hill reports (Al-Faruque, The Hill, 5/21).
Category Archives: Pharmaceutical
Published Report: FDA on GDUFA
The FDA has released its Performance Report for the first year of the Generic Drug User Fee Amendments (PDF downloadable at http://1.usa.gov/1dquler).
Careers … Young Scientist Scholarship Launched by iIroko Pharma & Penn
New Initiative Designed to Reward Philadelphia Students Pursuing Higher Education in the Sciences.
FDA Approves Xalkori for Late-stage Lung Cancer
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.
The Impact of Health Care Reform on the Pharmaceutical Industry
Overview Under the Affordable Care Act, President Obama signed into law the Patient Protection and Affordable Care Act (PPACA) on March 23, 2010. The PPACA proposes to extend healthcare to 32 million uninsured citizens under a health care system which will undergo a comprehensive reformation that will unfold over the next seven years. While most …
Continue reading “The Impact of Health Care Reform on the Pharmaceutical Industry”